Frontiers Current Pharmacological Strategies for Duchenne

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management - The Lancet Neurology

PDF) Current Pharmacological Strategies for Duchenne Muscular Dystrophy

Frontiers DMD Pluripotent Stem Cell Derived Cardiac Cells Recapitulate in vitro Human Cardiac Pathophysiology

Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function

Frontiers Drug development progress in duchenne muscular dystrophy

PDF) Current Pharmacological Strategies for Duchenne Muscular Dystrophy

Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future

Duchenne muscular dystrophy: Major trials to watch in 2023

Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model